SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $47,597,000 | +1136.0% | 275,430 | +721.8% | 0.05% | +1433.3% |
| Q4 2014 | $3,851,000 | +190.6% | 33,515 | +295.2% | 0.00% | +200.0% |
| Q3 2014 | $1,325,000 | -2.4% | 8,481 | -22.9% | 0.00% | 0.0% |
| Q2 2014 | $1,358,000 | +94.6% | 11,005 | +63.2% | 0.00% | 0.0% |
| Q1 2014 | $698,000 | -70.4% | 6,744 | -74.3% | 0.00% | -50.0% |
| Q4 2013 | $2,360,000 | -1.3% | 26,235 | -26.6% | 0.00% | 0.0% |
| Q3 2013 | $2,390,000 | +429.9% | 35,736 | +423.5% | 0.00% | – |
| Q2 2013 | $451,000 | – | 6,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |